SLC20A1: A Protein Regulating Glucose and Insulin Sensitivity

Target Name: SLC20A1

NCBI ID: G6574

SLC20A1

SLC20A1: A Protein Regulating Glucose and Insulin Sensitivity

SLC20A1 (Sodium-ATPase activator 20) is a protein that is expressed in various tissues and cells in the human body. It is a member of the SLC family of proteins, which are involved in the transport of various molecules across cell membranes. One of the functions of SLC20A1 is to regulate the intracellular concentration of glucose.

SLC20A1 is a 20-kDa protein that is expressed in the brain, heart, liver, and skeletal muscle. It is primarily localized to the endoplasmic reticulum (ER), where it is involved in the regulation of glucose uptake and release. SLC20A1 is also expressed in the cytoplasm and takes part in the transport of glucose across the endoplasmic reticulum.

SLC20A1 functions as a sodium-ATPase activator, which means that it protects cells from the harmful effects of high levels of sodium ions. Sodium ions are important for various physiological processes, including muscle contractions and nerve function. However, high levels of sodium ions can also cause various health problems, including muscle cramps, seizures, and heart arrhythmias. SLC20A1 helps to regulate the intracellular concentration of sodium ions, which is critical for maintaining the stability and health of cells.

SLC20A1 has also been shown to play a role in the regulation of insulin sensitivity. Insulin is a hormone that helps to lower blood sugar levels, and its sensitivity is regulated by various factors, including SLC20A1. SLC20A1 has been shown to interact with the protein GLUT1, which is involved in the regulation of insulin sensitivity. This interaction between SLC20A1 and GLUT1 suggests that SLC20A1 may be a potential drug target for the treatment of type 2 diabetes.

In addition to its role in the regulation of glucose and insulin sensitivity, SLC20A1 has also been shown to play a role in the regulation of pain perception. SLC20A1 is expressed in theEnteric nervous system (ENS), which is responsible for the regulation of pain perception. SLC20A1 has been shown to interact with the protein TrPV1, which is involved in the regulation of pain perception. This interaction between SLC20A1 and TrPV1 suggests that SLC20A1 may be a potential drug target for the treatment of chronic pain.

SLC20A1 is also involved in the regulation of cell signaling pathways. SLC20A1 has been shown to interact with the proteinFAK1, which is involved in the regulation of cell signaling pathways. This interaction between SLC20A1 and FAK1 suggests that SLC20A1 may be a potential drug target for the treatment of various types of cancer.

SLC20A1 is also expressed in various tissues and cells in the human body, which makes it a potential biomarker for a variety of diseases. For example, SLC20A1 has been shown to be elevated in the brains of individuals with Alzheimer's disease, which is a degenerative brain disorder characterized by the progressive loss of brain cells. This suggests that SLC20A1 may be a potential biomarker for the diagnosis and treatment of Alzheimer's disease.

In conclusion, SLC20A1 is a protein that is involved in the regulation of various physiological processes in the human body. Its functions include regulating the intracellular concentration of glucose and insulin sensitivity, as well as playing a role in the regulation of pain perception and cell signaling pathways. SLC20A1 is also expressed in various tissues and cells in the human body, which makes it a potential biomarker for a variety of diseases. Further research is needed to fully understand the role of SLC20A1 in the regulation of various physiological processes and its potential as a drug target or biomarker.

Protein Name: Solute Carrier Family 20 Member 1

Functions: Sodium-phosphate symporter which plays a fundamental housekeeping role in phosphate transport, such as absorbing phosphate from interstitial fluid for normal cellular functions such as cellular metabolism, signal transduction, and nucleic acid and lipid synthesis (PubMed:11009570, PubMed:7929240, PubMed:8041748, PubMed:19726692). May play a role in extracellular matrix and cartilage calcification as well as in vascular calcification (PubMed:11009570). Essential for cell proliferation but this function is independent of its phosphate transporter activity (PubMed:19726692)

The "SLC20A1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC20A1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets